References
- Hodson R. Inflammatory bowel disease. Nature. 2016 Dec 21;540(7634):S97. PubMed PMID: 28002398.
- Sachar DB. Ulcerative colitis: dead or alive. Ann Intern Med. 2015 Aug 18;163(4):316–317. PubMed PMID: 26167671.
- Buch KE. Inflammatory bowel disease. A clinical review of Crohn’s disease and ulcerative colitis. Adv Nurse Pract. 2007 Jul;15(7):57–60. PubMed PMID: 19998998.
- Guan Q, Zhang J. Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediators Inflamm. 2017;2017:4810258. PubMed PMID: 28420941; PubMed Central PMCID: PMCPMC5379128.
- Beermann J, Piccoli MT, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016 Oct;96(4):1297–1325. PubMed PMID: 27535639.
- Sanjay S, Girish C. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol. 2017 Apr;73(4):399–407. PubMed PMID: 28028586.
- Viennois E, Zhao Y, Han MK, et al. Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans. Sci Rep. 2017 May 31;7(1):2520. PubMed PMID: 28566745; PubMed Central PMCID: PMCPMC5451415.
- Benderska N, Dittrich AL, Knaup S, et al. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis. 2015 Sep;21(9):2039–2051. PubMed PMID: 26083618; PubMed Central PMCID: PMCPMC4603667.
- Netz U, Carter J, Eichenberger MR, et al. Plasma microRNA profile differentiates crohn’s colitis from ulcerative colitis. Inflamm Bowel Dis. 2017 Dec 19;24(1):159–165. PubMed PMID: 29272478; PubMed Central PMCID: PMCPMC5858028.
- Cai M, Chen S, Hu W. MicroRNA-141 is involved in ulcerative colitis pathogenesis via aiming at CXCL5. J Interferon Cytokine Res. 2017 Sep;37(9):415–420. PubMed PMID: 28854064.
- He C, Yu T, Shi Y, et al. MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1. Gastroenterology. 2017 May;152(6):1434–1448e15. PubMed PMID: 28193514.
- Cordes F, Bruckner M, Lenz P, et al. MicroRNA-320a strengthens intestinal barrier function and follows the course of experimental colitis. Inflamm Bowel Dis. 2016 Oct;22(10):2341–2355. PubMed PMID: 27607334.
- Koukos G, Polytarchou C, Kaplan JL, et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology. 2013 Oct;145(4):842–52e2. PubMed PMID: 23856509; PubMed Central PMCID: PMCPMC4427058.
- Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014 Nov;70(1):11–20. PubMed PMID: 24986424.
- Jordan SC, Choi J, Kim I, et al. Interleukin-6, A cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade. Transplantation. 2017 Jan;101(1):32–44. PubMed PMID: 27547870.
- Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016 Jun;64(6):1403–1415. PubMed PMID: 26867490.
- Leu CM, Wong FH, Chang C, et al. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene. 2003 Oct 30;22(49):7809–7818. PubMed PMID: 14586407.
- Parisinos CA, Serghiou S, Katsoulis M, et al. Variation in interleukin 6 receptor gene associates with risk of crohn’s disease and ulcerative colitis. Gastroenterology. 2018 Aug;155(2):303–306e2. PubMed PMID: 29775600; PubMed Central PMCID: PMCPMC6083435.
- Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K. Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol. 2018 Dec 19;30(1):1–10. PubMed PMID: 30063466.
- Lu X, Yu Y, Tan S. The role of the miR-21-5p-mediated inflammatory pathway in ulcerative colitis. Exp Ther Med. 2020 Feb;19(2):981–989. PubMed PMID: 32010260; PubMed Central PMCID: PMCPMC6966149.
- Li M, Zhang S, Qiu Y, et al. Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3. Cell Death Dis. 2017 Mar 23;8(3):e2699. PubMed PMID: 28333149; PubMed Central PMCID: PMCPMC5386569.
- Singh C, Roy-Chowdhuri S. Quantitative real-time PCR: recent advances. Methods Mol Biol. 2016;1392:161–176. PubMed PMID: 26843055.
- Chen Y, Le TH, Du Q, et al. Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling. Int Immunopharmacol. 2019 Jun;71:144–154. PubMed PMID: 30901677.
- Ren MT, Gu ML, Zhou XX, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World J Gastroenterol. 2019 Oct 14;25(38):5800–5813. PubMed PMID: 31636473; PubMed Central PMCID: PMCPMC6801188.
- Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation-function-future. Int J Mol Sci. 2016 Dec 2. 17(12). PubMed PMID: 27918449; PubMed Central PMCID: PMCPMC5187828. eng. DOI: 10.3390/ijms17122028
- Xie Y, Chen Y, Zhang L, et al. The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling. J Cell Mol Med. 2017 May;21(5):1033–1041. PubMed PMID: 27878944; PubMed Central PMCID: PMCPMC5387131. eng.
- Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012 Nov 3;380(9853):1606–1619. PubMed PMID: 22914296.
- Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol. 2018 Jan 7;24(1):5–14. PubMed PMID: 29358877; PubMed Central PMCID: PMCPMC5757125.
- Soroosh A, Rankin CR, Polytarchou C, et al. miR-24 is elevated in ulcerative colitis patients and regulates intestinal epithelial barrier function. Am J Pathol. 2019 Sep;189(9):1763–1774. PubMed PMID. 31220450; PubMed Central PMCID: PMCPMC6723227.
- Deng F, He S, Cui S, et al. A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages. J Crohns Colitis. 2019 Mar 30;13(4):482–494. PubMed PMID: 30445446.
- Deng S, Wang H, Fan H, et al. Over-expressed miRNA-200b ameliorates ulcerative colitis-related colorectal cancer in mice through orchestrating epithelial-mesenchymal transition and inflammatory responses by channel of AKT2. Int Immunopharmacol. 2018 Aug;61:346–354. PubMed PMID: 29933193.
- Yang Y, Ma Y, Shi C, et al. Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun. 2013 May 17;434(4):746–752. PubMed PMID: 23583411.
- Ma J, Yin G, Lu Z, et al. Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF-kappaB pathway and ROS signaling. Phytother Res. 2018 Sep;32(9):1770–1783. PubMed PMID: 29876982.
- Chu XQ, Wang J, Chen GX, et al. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis. Pathol Res Pract. 2018 Jan;214(1):151–162. PubMed PMID: 29129493.
- Chen B, She S, Li D, et al. Role of miR-19a targeting TNF-alpha in mediating ulcerative colitis. Scand J Gastroenterol. 2013 Jul;48(7):815–824. PubMed PMID: 23795660.